Cargando…

Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants

BACKGROUND AND PURPOSE: Renal excretion of direct oral anticoagulants (DOACs) varies depending on the drug. Hypothetically, an increased glomerular filtration rate (GFR) may lead to suboptimal dosing and a higher thromboembolic events incidence. However, real-world patient data do not support the th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corrochano, Mariana, Acosta-Isaac, René, Plaza, Melania, Muñoz, Rodrigo, Mojal, Sergi, Moret, Carla, Souto, Joan Carles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733869/ https://www.ncbi.nlm.nih.gov/pubmed/36490245 http://dx.doi.org/10.1371/journal.pone.0278693

Ejemplares similares

Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data
por: Moret, Carla, et al.
Publicado: (2023)

Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19
por: Corrochano, Mariana, et al.
Publicado: (2021)

TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism
por: Canyelles, Marina, et al.
Publicado: (2022)

Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings
por: Takatsuki, Seiji, et al.
Publicado: (2017)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
por: Ferrandis, Raquel, et al.
Publicado: (2020)

What can we learn from real world studies on direct oral anticoagulants?
por: Coppens, M.
Publicado: (2017)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Gustafson, Whitney L., et al.
Publicado: (2019)

Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
por: Roberti, Roberta, et al.
Publicado: (2021)

To learn or not to learn from real-world experience on direct oral anticoagulants in pediatric patients?
por: Streif, Werner
Publicado: (2023)

Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2022)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease
por: Sans, Laia, et al.
Publicado: (2017)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: clinical outcomes in a single centre cohort after long-term follow-up
por: Corrochano, M., et al.
Publicado: (2020)

Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review()
por: Li, Allen, et al.
Publicado: (2020)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects
por: Hutto, David, et al.
Publicado: (2022)

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis
por: Soria, José Manuel, et al.
Publicado: (2022)

Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings
por: Menéndez-Jándula, Bárbara, et al.
Publicado: (2019)

Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data
por: Bean, Daniel M., et al.
Publicado: (2019)

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
por: Vinogradova, Yana, et al.
Publicado: (2018)

Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin
por: Pyykönen, Mikko, et al.
Publicado: (2021)

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
por: Srikajornlarp, Saowaluk, et al.
Publicado: (2022)

Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist
por: Carles, Misericòrdia, et al.
Publicado: (2015)

Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients
por: Joung, Boyoung
Publicado: (2017)

Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants
por: Camm, A John, et al.
Publicado: (2018)

Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
por: Anghel, Larisa, et al.
Publicado: (2020)

Correction to: Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings
por: Menéndez-Jándula, Bárbara, et al.
Publicado: (2019)

Real World Outcomes of Therapeutic Anticoagulation Use in Moderate COVID-19 Infection in Hospitalised Patients
por: Creeper, Katherine J., et al.
Publicado: (2022)

Long-term effectiveness and safety of non-vitamin K antagonist anticoagulant in real world practice
por: Roh, S Y, et al.
Publicado: (2023)

Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
por: Pham, Phuong N., et al.
Publicado: (2019)

Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting
por: Perrone, Valentina, et al.
Publicado: (2022)

Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
por: Sans, Laia, et al.
Publicado: (2016)

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2019)

Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
por: Zhang, Jinhua, et al.
Publicado: (2020)

Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study
por: Pericay, Carles, et al.
Publicado: (2023)

Design characteristics, primary stability and risk of fracture of orthodontic mini-implants: Pilot scan electron microscope and mechanical studies
por: Walter, André, et al.
Publicado: (2013)

Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants
por: Meid, Andreas D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3viutccq8td03t9bvsff8g4c55